ALLIANCEBERNSTEIN L.P. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$189,000
-33.9%
63,800
+0.3%
0.00%
Q4 2021$286,000
-7.4%
63,6000.0%0.00%
Q3 2021$309,000
-28.8%
63,6000.0%0.00%
Q2 2021$434,000
+14.2%
63,600
+18.2%
0.00%
Q1 2021$380,000
+4.4%
53,800
-7.6%
0.00%
Q4 2020$364,000
+8.7%
58,200
-6.1%
0.00%
Q3 2020$335,000
+3.4%
62,0000.0%0.00%
Q2 2020$324,000
+82.0%
62,000
+9.9%
0.00%
Q1 2020$178,000
-4.8%
56,400
+21.8%
0.00%
Q4 2019$187,000
-6.5%
46,3000.0%0.00%
Q3 2019$200,000
+8.1%
46,3000.0%0.00%
Q2 2019$185,000
-21.9%
46,300
+4.8%
0.00%
Q1 2019$237,0000.0%44,200
-4.3%
0.00%
Q4 2018$237,000
-44.8%
46,200
+4.5%
0.00%
Q3 2018$429,000
-4.9%
44,2000.0%0.00%
Q2 2018$451,000
+2.7%
44,200
+30.8%
0.00%
Q1 2018$439,000
-7.8%
33,800
+27.1%
0.00%
Q4 2017$476,000
-28.7%
26,6000.0%0.00%
-100.0%
Q3 2017$668,000
+32.5%
26,600
+27.3%
0.00%
Q2 2017$504,000
+114.5%
20,900
+71.3%
0.00%
Q1 2017$235,000
+25.0%
12,2000.0%0.00%
Q4 2016$188,000
+32.4%
12,200
+11.9%
0.00%
Q3 2016$142,00010,9000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 753,882$3,257,0007.69%
Omega Fund Management, LLC 2,600,410$11,234,0003.47%
Abingworth LLP 1,041,131$4,508,0002.85%
ICM ASSET MANAGEMENT INC/WA 285,315$1,233,0000.95%
Arbiter Partners Capital Management LLC 1,106,422$4,780,0000.87%
Trellus Management Company, LLC 185,000$799,0000.80%
ARMISTICE CAPITAL, LLC 1,572,000$6,791,0000.45%
GENERAL AMERICAN INVESTORS CO INC 749,660$3,239,0000.32%
NEXPOINT ASSET MANAGEMENT, L.P. 966,493$4,176,0000.26%
Bruce & Co., Inc. 266,552$1,151,0000.24%
View complete list of PARATEK PHARMACEUTICALS INC shareholders